News
Paul Reider has followed Coherus BioSciences’ last biosimilar product out the door. | Paul Reider has followed Coherus ...
Barchart on MSN4d
Amgen's Quarterly Earnings Preview: What You Need to KnowWith a market cap of $149.1 billion, Amgen Inc. (AMGN) is renowned for its innovative human therapeutics across oncology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback